Objective: This paper aimed to investigate the PI3K/Akt/mTOR signal-pathway regulator factor-related lncRNAsignatures (PAM-SRFLncSigs). associated with regulators of the indicated signaling pathway in patients with lungadenocarcinoma (LUAD) undergoing immunotherapy. Materials and Methods: In this retrospective study. we employed univariate Cox. https://www.chiggate.com/voyage-et-cie-5-3-wick-candle-discount/